Watch Demo

Precision Medicine Market Research Report by Technology, Application, End-User, Deployment, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Precision Medicine Market Research Report by Technology, Application, End-User, Deployment, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:141

  • Report ID:6405075

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Precision Medicine Market Research Report by Technology (Big Data Analytics, Bioinformatics, and Companion Diagnostics), Application, End-User, Deployment, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

The United States Precision Medicine Market size was estimated at USD 13.12 billion in 2022 and expected to reach USD 14.92 billion in 2023, projecting growth at a CAGR of 11.87% to reach USD 32.19 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Precision Medicine Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Precision Medicine Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Precision Medicine Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Precision Medicine Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Precision Medicine Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market is studied across Big Data Analytics, Bioinformatics, Companion Diagnostics, Drug Discovery, and Gene Sequencing.

Based on Application, the market is studied across CNS, Immunology, Oncology, and Respiratory.

Based on End-User, the market is studied across Biotechnology & Diagnostic Companies, Laboratories & Pharmaceuticals, and Research Centers & Government Institutions.

Based on Deployment, the market is studied across On-Cloud and On-Premise.

Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Precision Medicine Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Precision Medicine Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Precision Medicine Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Precision Medicine Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Precision Medicine Market, including 2bPrecise, Biocrates Life Sciences AG, Caris Life Sciences, Eagle Genomics Ltd., Intomics, Kailos Genetics, LLC, Laboratory Corporation of America Holdings, Medtronic PLC, Novartis AG, Pfizer Inc., Precision Medicine Group, LLC, Quest Diagnostics Incorporated, Syapse, Inc., Teva Pharmaceutical Industries Ltd., and TIGAR Health Technologies.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Precision Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Precision Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Precision Medicine Market?
4. What is the competitive strategic window for opportunities in the United States Precision Medicine Market?
5. What are the technology trends and regulatory frameworks in the United States Precision Medicine Market?
6. What is the market share of the leading vendors in the United States Precision Medicine Market?
7. What modes and strategic moves are considered suitable for entering the United States Precision Medicine Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing government funding and rising online collaborative forums
5.1.1.2. Pharmaceutical and software companies to characterize the genes
5.1.2. Restraints
5.1.2.1. High cost associated with the deployment
5.1.3. Opportunities
5.1.3.1. Integration of advanced technology for development of precision medicine
5.1.4. Challenges
5.1.4.1. Issues associated with the data sharing
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Precision Medicine Market, by Technology
6.1. Introduction
6.2. Big Data Analytics
6.3. Bioinformatics
6.4. Companion Diagnostics
6.5. Drug Discovery
6.6. Gene Sequencing

7. Precision Medicine Market, by Application
7.1. Introduction
7.2. CNS
7.3. Immunology
7.4. Oncology
7.5. Respiratory

8. Precision Medicine Market, by End-User
8.1. Introduction
8.2. Biotechnology & Diagnostic Companies
8.3. Laboratories & Pharmaceuticals
8.4. Research Centers & Government Institutions

9. Precision Medicine Market, by Deployment
9.1. Introduction
9.2. On-Cloud
9.3. On-Premise

10. California Precision Medicine Market
10.1. Introduction

11. Florida Precision Medicine Market
11.1. Introduction

12. Illinois Precision Medicine Market
12.1. Introduction

13. New York Precision Medicine Market
13.1. Introduction

14. Ohio Precision Medicine Market
14.1. Introduction

15. Pennsylvania Precision Medicine Market
15.1. Introduction

16. Texas Precision Medicine Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. 2bPrecise
18.2. Biocrates Life Sciences AG
18.3. Caris Life Sciences
18.4. Eagle Genomics Ltd.
18.5. Intomics
18.6. Kailos Genetics, LLC
18.7. Laboratory Corporation of America Holdings
18.8. Medtronic PLC
18.9. Novartis AG
18.10. Pfizer Inc.
18.11. Precision Medicine Group, LLC
18.12. Quest Diagnostics Incorporated
18.13. Syapse, Inc.
18.14. Teva Pharmaceutical Industries Ltd.
18.15. TIGAR Health Technologies

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES PRECISION MEDICINE MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES PRECISION MEDICINE MARKET DYNAMICS
FIGURE 8. UNITED STATES PRECISION MEDICINE MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 11. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 12. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, 2018-2030 (USD BILLION)
FIGURE 13. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
FIGURE 14. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD BILLION)
FIGURE 15. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD BILLION)
FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, 2018-2030 (USD BILLION)
FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 19. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 20. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, 2018-2030 (USD BILLION)
FIGURE 21. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD BILLION)
FIGURE 22. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
FIGURE 23. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD BILLION)
FIGURE 24. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 25. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 26. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 27. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, 2018-2030 (USD BILLION)
FIGURE 28. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, 2018-2030 (USD BILLION)
FIGURE 29. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, 2018-2030 (USD BILLION)
FIGURE 30. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 32. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY DEPLOYMENT, 2030
FIGURE 33. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, 2018-2030 (USD BILLION)
FIGURE 34. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, 2018-2030 (USD BILLION)
FIGURE 35. CALIFORNIA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 36. FLORIDA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 37. ILLINOIS PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 38. NEW YORK PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 39. OHIO PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 40. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 41. TEXAS PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 43. UNITED STATES PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 44. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. UNITED STATES PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 5. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 6. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, 2018-2030 (USD BILLION)
TABLE 7. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, BY STATE, 2018-2030 (USD BILLION)
TABLE 8. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
TABLE 9. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY STATE, 2018-2030 (USD BILLION)
TABLE 10. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD BILLION)
TABLE 11. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY STATE, 2018-2030 (USD BILLION)
TABLE 12. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD BILLION)
TABLE 13. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2030 (USD BILLION)
TABLE 14. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, 2018-2030 (USD BILLION)
TABLE 15. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, BY STATE, 2018-2030 (USD BILLION)
TABLE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, 2018-2030 (USD BILLION)
TABLE 18. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, BY STATE, 2018-2030 (USD BILLION)
TABLE 19. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD BILLION)
TABLE 20. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2018-2030 (USD BILLION)
TABLE 21. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
TABLE 22. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2030 (USD BILLION)
TABLE 23. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD BILLION)
TABLE 24. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, BY STATE, 2018-2030 (USD BILLION)
TABLE 25. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 26. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, 2018-2030 (USD BILLION)
TABLE 27. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY & DIAGNOSTIC COMPANIES, BY STATE, 2018-2030 (USD BILLION)
TABLE 28. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, 2018-2030 (USD BILLION)
TABLE 29. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, BY STATE, 2018-2030 (USD BILLION)
TABLE 30. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, 2018-2030 (USD BILLION)
TABLE 31. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, BY STATE, 2018-2030 (USD BILLION)
TABLE 32. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 33. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, 2018-2030 (USD BILLION)
TABLE 34. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, BY STATE, 2018-2030 (USD BILLION)
TABLE 35. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, 2018-2030 (USD BILLION)
TABLE 36. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, BY STATE, 2018-2030 (USD BILLION)
TABLE 37. CALIFORNIA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 38. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 39. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 40. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 41. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 42. FLORIDA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 43. FLORIDA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 44. FLORIDA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 45. FLORIDA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 46. FLORIDA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 47. ILLINOIS PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 48. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 49. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 50. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 51. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 52. NEW YORK PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 53. NEW YORK PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 54. NEW YORK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 55. NEW YORK PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 56. NEW YORK PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 57. OHIO PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 58. OHIO PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 59. OHIO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 60. OHIO PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 61. OHIO PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 62. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 63. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 64. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 65. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 66. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 67. TEXAS PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 68. TEXAS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 69. TEXAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 70. TEXAS PRECISION MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 71. TEXAS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD BILLION)
TABLE 72. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 73. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 74. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 75. UNITED STATES PRECISION MEDICINE MARKET RANKING, BY KEY PLAYER, 2022
TABLE 76. UNITED STATES PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 77. UNITED STATES PRECISION MEDICINE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 78. UNITED STATES PRECISION MEDICINE MARKET MERGER & ACQUISITION
TABLE 79. UNITED STATES PRECISION MEDICINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 80. UNITED STATES PRECISION MEDICINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 81. UNITED STATES PRECISION MEDICINE MARKET INVESTMENT & FUNDING
TABLE 82. UNITED STATES PRECISION MEDICINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 83. UNITED STATES PRECISION MEDICINE MARKET: LICENSE & PRICING

Companies Mentioned

2bPrecise
Biocrates Life Sciences AG
Caris Life Sciences
Eagle Genomics Ltd.
Intomics
Kailos Genetics, LLC
Laboratory Corporation of America Holdings
Medtronic PLC
Novartis AG
Pfizer Inc.
Precision Medicine Group, LLC
Quest Diagnostics Incorporated
Syapse, Inc.
Teva Pharmaceutical Industries Ltd.
TIGAR Health Technologies

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.